5 Best Twist Bioscience Alternatives for Synthetic Biology and Protein Production
Twist Bioscience is a leader in DNA synthesis, but modern drug discovery often requires faster, more cost-effective ways to move from DNA sequences to functional proteins.
Invitris Team
Founder, Invitris
Twist Bioscience has become a standard for high-throughput DNA synthesis using its silicon-based platform. However, for researchers focused on drug discovery and protein engineering, DNA is only the first step. The bottleneck often lies in expressing that DNA into functional proteins. This list explores alternatives that either offer similar DNA synthesis services or provide more efficient pathways to final biological products.
First, what is Twist Bioscience?
Best for: Large-scale genomic research and organizations needing massive quantities of custom DNA sequences.
Strengths
- High-throughput silicon-based DNA synthesis platform
- Cost-effective for large-scale DNA libraries and NGS target enrichment
- Broad product portfolio including oligo pools and IgG proteins
Where it falls short
- Turnaround times can be lengthy for complex gene sequences
- Traditional cell-based protein expression remains a separate, slower step
- Logistical complexity when scaling from DNA to functional drug candidates
The top alternatives
- #1Top pick
Invitris: Direct DNA-to-Protein Synthesis
Invitris simplifies biological drug creation by bypassing traditional cell-based expression. While Twist focuses on the DNA itself, Invitris uses a patent-pending platform to turn DNA directly into synthetic proteins. This technology, recently featured in Science magazine, is designed to make drug development significantly more efficient by reducing material costs and increasing production speed.
- Eliminates the need for living cell cultures in protein production
- Reduces material costs by up to 100x compared to traditional methods
- Enables rapid synthesis of bacteriophages for antibiotic-resistant infections
- Increases production efficiency by over 10,000x for specific biological drugs
Side-by-side comparison
| Category | Invitris | Twist Bioscience | Edge |
|---|---|---|---|
| Primary Output | Functional Synthetic Proteins | Synthetic DNA / Oligos | Neck-and-neck |
| Production Method | Cell-free platform | Silicon-based DNA synthesis | Stronger |
| Material Cost | 100x lower than standard | Industry standard (low for DNA) | Stronger |
| Turnaround Speed | Hours to days for proteins |
Frequently asked questions
Is Invitris a direct competitor to Twist Bioscience?
Not exactly. Twist Bioscience is primarily a DNA synthesis company. Invitris is a protein synthesis platform. Invitris is an alternative for teams who currently buy DNA from Twist to express proteins, offering a faster way to get to the final protein product.
Why would I choose IDT over Twist?
IDT is often preferred for smaller, custom orders of oligos and primers where speed and technical support are more critical than the massive scale Twist provides.
Accelerate Your Protein Drug Discovery
Move beyond DNA synthesis and start producing functional proteins at a fraction of the cost.
Learn more about Invitris